tumor
→
HasA
→
same targets
|
0.51
|
|
tumor
→
HasA
→
poor prognosis
|
0.47
|
|
tumor
→
HasA
→
a lot of mutations
|
0.46
|
|
tumor
→
HasA
→
good prognosis
|
0.42
|
|
tumor
→
HasA
→
worse prognosis
|
0.39
|
|
tumor
→
HasA
→
high recurrence rate
|
0.39
|
|
tumor
→
HasA
→
specific gene mutations
|
0.38
|
|
tumor
→
HasA
→
predilection
|
0.37
|
|
tumor
→
HasA
→
specific genetic changes
|
0.36
|
|
tumor
→
HasA
→
aggressive behavior
|
0.36
|
|
tumor
→
HasA
→
egfr exon 19 deletions
|
0.35
|
|
tumor
→
HasA
→
egfr mutations
|
0.35
|
|
tumor
→
HasA
→
high cell turnover
|
0.35
|
|
tumor
→
HasA
→
abnormality
|
0.33
|
|
tumor
→
HasA
→
exon 21 l858rsubstitution mutat…
|
0.32
|
|
tumor
→
HasA
→
specific genetic marker
|
0.32
|
|
tumor
→
HasA
→
better prognosis
|
0.31
|
|
tumor
→
HasA
→
loh
|
0.31
|
|
tumor
→
HasA
→
low expression
|
0.31
|
|
tumor
→
HasA
→
endothelium-lined channels
|
0.30
|
|
tumor
→
HasA
→
higher likelihood
|
0.30
|
|
tumor
→
HasA
→
epidermal growth factor receptor
|
0.28
|
|
tumor
→
HasA
→
different prognosis
|
0.27
|
|
tumor
→
HasA
→
distinct clinical presentations
|
0.27
|
|
tumor
→
HasA
→
few mutations
|
0.27
|
|
tumor
→
HasA
→
high anti-cd44s positivity
|
0.27
|
|
tumor
→
HasA
→
one high-risk feature
|
0.27
|
|
tumor
→
HasA
→
stalk
|
0.27
|
|
tumor
→
HasA
→
cancer
|
0.25
|
|
tumor
→
HasA
→
malignant cells
|
0.25
|
|
tumor
→
HasA
→
outcome
|
0.25
|
|
tumor
→
HasA
→
high risk
|
0.24
|
|
tumor
→
HasA
→
extensive invasion
|
0.21
|
|
tumor
→
HasA
→
many different types of cells
|
0.20
|
|
tumor
→
HasA
→
excellent prognosis
|
0.18
|
|